In fact, we also identified 2 new compounds (vestitol and glabrone) and 2 new targets (PTEN and MAP3K8) that have not yet been demonstrated to be directly associated with the treatment of COVID-19, but have been attested to have a role in the treatment of COVID-19-related diseases (e.g. hepatitis B, influenza A virus). This evidence concerns the gene PTEN and COVID-19.